Bioprinting places cells or materials in a planned arrangement; the constructed tissue still needs structural and functional checks.
Bioprinting controls deposition of biological materials to build an experimental construct. The printing plan, measured final geometry, viable cells and biological function are distinct evidence. Kolesky and colleagues printed cell-containing and removable inks, removed the temporary channel material, added endothelial lining and perfused engineered tissues. This tissue-engineering experiment did not demonstrate a complete human organ or cancer-treatment utility. Yi and colleagues reported a particular glioblastoma chip combining patient-derived tumour cells, endothelial cells and brain-derived matrix; its abstract supports that bounded example.
Deposit defined cells and materials in a planned arrangement, then verify constructed geometry, cell health and the intended function.
Query for this technology: (TITLE:"Bioprinting of experimental tissue models" OR ABSTRACT:"Bioprinting of experimental tissue models") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Bioprinting of experimental tissue models, not a curated reading list.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/